Selected research
Industry Research
Oral Testosterone Industry Research Report 2026
Market perspective
The global Oral Testosterone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oral Testosterone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oral Testosterone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oral Testosterone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oral Testosterone include Zhejiang Medicine, Tianjin Lisheng Pharmaceutical, Novo Nordisk, Mylan, Bayer, Sunpharma, Power Health, Organon and Marius Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oral Testosterone market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oral Testosterone Market by Company
Zhejiang Medicine
Tianjin Lisheng Pharmaceutical
Novo Nordisk
Mylan
Bayer
Sunpharma
Power Health
Organon
Marius Pharmaceuticals
Endo Pharmaceuticals
Clarus Therapeutics
Ardana
Antares Pharma
Oral Testosterone Segment by Type
Capsules
Tablets
Oral Testosterone Segment by Application
Medical
Research
Oral Testosterone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Testosterone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Testosterone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Testosterone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral Testosterone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral Testosterone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral Testosterone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Tablets
Applications
- Medical
- Research
Companies covered
- Zhejiang Medicine
- Tianjin Lisheng Pharmaceutical
- Novo Nordisk
- Mylan
- Bayer
- Sunpharma
- Power Health
- Organon
- Marius Pharmaceuticals
- Endo Pharmaceuticals
- Clarus Therapeutics
- Ardana
- Antares Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oral Testosterone Market Size (2021-2032)
- 2.2.2 Global Oral Testosterone Sales (2021-2032)
- 2.2.3 Global Oral Testosterone Market Average Price (2021-2032)
- 2.3 Oral Testosterone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsules
- 2.3.3 Tablets
- 2.4 Oral Testosterone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical
- 2.4.3 Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oral Testosterone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oral Testosterone Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Oral Testosterone Revenue of Manufacturers (2021-2026)
- 3.4 Global Oral Testosterone Average Price by Manufacturers (2021-2026)
- 3.5 Global Oral Testosterone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oral Testosterone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oral Testosterone, Product Type & Application
- 3.8 Global Manufacturers of Oral Testosterone, Established Date
- 3.9 Global Oral Testosterone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Medicine
- 4.1.1 Zhejiang Medicine Company Information
- 4.1.2 Zhejiang Medicine Business Overview
- 4.1.3 Zhejiang Medicine Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Medicine Oral Testosterone Product Portfolio
- 4.1.5 Zhejiang Medicine Recent Developments
- 4.2 Tianjin Lisheng Pharmaceutical
- 4.2.1 Tianjin Lisheng Pharmaceutical Company Information
- 4.2.2 Tianjin Lisheng Pharmaceutical Business Overview
- 4.2.3 Tianjin Lisheng Pharmaceutical Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tianjin Lisheng Pharmaceutical Oral Testosterone Product Portfolio
- 4.2.5 Tianjin Lisheng Pharmaceutical Recent Developments
- 4.3 Novo Nordisk
- 4.3.1 Novo Nordisk Company Information
- 4.3.2 Novo Nordisk Business Overview
- 4.3.3 Novo Nordisk Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novo Nordisk Oral Testosterone Product Portfolio
- 4.3.5 Novo Nordisk Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Oral Testosterone Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Bayer
- 4.5.1 Bayer Company Information
- 4.5.2 Bayer Business Overview
- 4.5.3 Bayer Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer Oral Testosterone Product Portfolio
- 4.5.5 Bayer Recent Developments
- 4.6 Sunpharma
- 4.6.1 Sunpharma Company Information
- 4.6.2 Sunpharma Business Overview
- 4.6.3 Sunpharma Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sunpharma Oral Testosterone Product Portfolio
- 4.6.5 Sunpharma Recent Developments
- 4.7 Power Health
- 4.7.1 Power Health Company Information
- 4.7.2 Power Health Business Overview
- 4.7.3 Power Health Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Power Health Oral Testosterone Product Portfolio
- 4.7.5 Power Health Recent Developments
- 4.8 Organon
- 4.8.1 Organon Company Information
- 4.8.2 Organon Business Overview
- 4.8.3 Organon Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Organon Oral Testosterone Product Portfolio
- 4.8.5 Organon Recent Developments
- 4.9 Marius Pharmaceuticals
- 4.9.1 Marius Pharmaceuticals Company Information
- 4.9.2 Marius Pharmaceuticals Business Overview
- 4.9.3 Marius Pharmaceuticals Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Marius Pharmaceuticals Oral Testosterone Product Portfolio
- 4.9.5 Marius Pharmaceuticals Recent Developments
- 4.10 Endo Pharmaceuticals
- 4.10.1 Endo Pharmaceuticals Company Information
- 4.10.2 Endo Pharmaceuticals Business Overview
- 4.10.3 Endo Pharmaceuticals Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Endo Pharmaceuticals Oral Testosterone Product Portfolio
- 4.10.5 Endo Pharmaceuticals Recent Developments
- 4.11 Clarus Therapeutics
- 4.11.1 Clarus Therapeutics Company Information
- 4.11.2 Clarus Therapeutics Business Overview
- 4.11.3 Clarus Therapeutics Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Clarus Therapeutics Oral Testosterone Product Portfolio
- 4.11.5 Clarus Therapeutics Recent Developments
- 4.12 Ardana
- 4.12.1 Ardana Company Information
- 4.12.2 Ardana Business Overview
- 4.12.3 Ardana Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ardana Oral Testosterone Product Portfolio
- 4.12.5 Ardana Recent Developments
- 4.13 Antares Pharma
- 4.13.1 Antares Pharma Company Information
- 4.13.2 Antares Pharma Business Overview
- 4.13.3 Antares Pharma Oral Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Antares Pharma Oral Testosterone Product Portfolio
- 4.13.5 Antares Pharma Recent Developments
5 Global Oral Testosterone Market Scenario by Region
- 5.1 Global Oral Testosterone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oral Testosterone Sales by Region: 2021-2032
- 5.2.1 Global Oral Testosterone Sales by Region: 2021-2026
- 5.2.2 Global Oral Testosterone Sales by Region: 2027-2032
- 5.3 Global Oral Testosterone Revenue by Region: 2021-2032
- 5.3.1 Global Oral Testosterone Revenue by Region: 2021-2026
- 5.3.2 Global Oral Testosterone Revenue by Region: 2027-2032
- 5.4 North America Oral Testosterone Market Facts & Figures by Country
- 5.4.1 North America Oral Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oral Testosterone Sales by Country (2021-2032)
- 5.4.3 North America Oral Testosterone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Oral Testosterone Market Facts & Figures by Country
- 5.5.1 Europe Oral Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oral Testosterone Sales by Country (2021-2032)
- 5.5.3 Europe Oral Testosterone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Oral Testosterone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oral Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oral Testosterone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oral Testosterone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oral Testosterone Market Facts & Figures by Country
- 5.7.1 South America Oral Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oral Testosterone Sales by Country (2021-2032)
- 5.7.3 South America Oral Testosterone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Oral Testosterone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oral Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oral Testosterone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oral Testosterone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Oral Testosterone Sales by Type (2021-2032)
- 6.1.1 Global Oral Testosterone Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Oral Testosterone Sales Market Share by Type (2021-2032)
- 6.2 Global Oral Testosterone Revenue by Type (2021-2032)
- 6.2.1 Global Oral Testosterone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oral Testosterone Revenue Market Share by Type (2021-2032)
- 6.3 Global Oral Testosterone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oral Testosterone Sales by Application (2021-2032)
- 7.1.1 Global Oral Testosterone Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Oral Testosterone Sales Market Share by Application (2021-2032)
- 7.2 Global Oral Testosterone Revenue by Application (2021-2032)
- 7.2.1 Global Oral Testosterone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oral Testosterone Revenue Market Share by Application (2021-2032)
- 7.3 Global Oral Testosterone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oral Testosterone Value Chain Analysis
- 8.1.1 Oral Testosterone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oral Testosterone Production Mode & Process
- 8.2 Oral Testosterone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oral Testosterone Distributors
- 8.2.3 Oral Testosterone Customers
9 Global Oral Testosterone Analyzing Market Dynamics
- 9.1 Oral Testosterone Industry Trends
- 9.2 Oral Testosterone Industry Drivers
- 9.3 Oral Testosterone Industry Opportunities and Challenges
- 9.4 Oral Testosterone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst